"PARP inhibitors have been a mainstay in the treatment of metastatic castration-resistant prostate cancer for patients with ...

The FDA has already approved PARP inhibitors in certain patients with metastatic castration-resistant prostate cancer (mCRPC) ...

Metastatic prostate cancer can progress in different ways. In some men the disease advances rapidly, while other men have ...

ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Ravi Madan discussing preliminary data from 6 month follow-up assessing prospective monitoring of PSMA–positive ...

Zejula with Zytiga and prednisone delayed cancer growth and symptoms in patients with castration-sensitive prostate cancer ...

Novartis has reported topline outcomes from the Phase III PSMAddition trial’s pre-specified interim analysis of Pluvicto.

Enlarged prostate does not cause prostate cancer, but both are common among older men. A North Texas urologist explains why ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...

Former President Joe Biden was diagnosed with an aggressive form of prostate cancer. What does it mean in terms of prognosis ...

The form of cancer Joe Biden has is one of the most common cancers to affect men. Here are the warning signs to watch out for ...

By Carla K. Johnson, Associated Press Former President Joe Biden has been diagnosed with aggressive prostate cancer and is ...

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That’s why Dr. Carlos Varga ...